Blogs - Global Pricing

Navigating the pricing landscape: A year of innovation, insight, and impact

By Wayne Speechly, CEO
2 December 2024

Read More

Insights into value-based pricing approaches for oncology products in Germany

29 November 2024

Read More

When is the Exciting Promise of AI in Pharmaceutical Pricing and Market Access Coming?

28 November 2024

Read More

GPI launches oncology-specific value-based pricing methodology

1 November 2024

Read More

The proposed EU HTA, a concern for orphan drugs in the future?

27 February 2023

Read More

Is Gene Therapy still on the brink of Commercial Success?

8 February 2023

Read More

Default Image

State Price Transparency Reporting: 4 strategies to reduce the risk of non-compliance

23 November 2022

Read More

Default Image

Starting with the end in mind – creating sustainable access to medicines

9 November 2022

Read More

Default Image

Stairway to Seven: GPI celebrating 7 years in business

29 September 2022

Read More

Default Image

What should drug pricing reforms look like in the United States?

By Margaret Labban, PhD
1 June 2022

Read More